- ►diabetesjournals.org GB Bolli, D Kerr, R Thomas, E Torlone, A … - Diabetes Care, 2009 - Am Diabetes Assoc OBJECTIVE Insulin pump therapy (continuous subcutaneous insulin infusion [CSII])
and multiple daily injections (MDIs) with insulin glargine as basal insulin and
mealtime insulin lispro have not been prospectively compared in people ... Cited by 2 - Related articles - All 2 versions
J Dormandy, M Bhattacharya, ART de Bruyn - Drug Safety, 2009 - ingentaconnect.com Abstract People with type 2 diabetes mellitus have an excess risk of
macrovascular disease and a poorer prognosis. PROactive (PROspective
pioglitAzone Clinical Trial In macroVascular Events) was a landmark study ... Cited by 4 - Related articles - All 4 versions
HP Chase, S Arslanian, NH White, WV … - The Journal of Pediatrics, 2008 - Elsevier The overall mean change in A1C from baseline to week 24 was similar in the 2
groups: insulin glargine (n = 76), −0.25% ± 0.14%; NPH/Lente (n = 81), 0.05%
± 0.13% (P = .1725). However, an analysis of covariance, adjusting for ... Cited by 5 - Related articles - All 6 versions
R Chen, A Ben-Haroush, A Weissman- … - American Journal of Obstetrics and Gynecology, 2007 - Elsevier Overall, 90 women were evaluated; of them 30 were treated by CSII and 60 by MDI.
No between-group differences were found in maternal age, nulliparity rate,
severity and duration of diabetes, prepregnancy body mass index, and weight ... Cited by 7 - Related articles - All 14 versions
KJ Leveno, SJ Fortunato, P Raskin, ML … - Diabetes research and clinical practice, 1988 - ncbi.nlm.nih.gov The development of battery-powered pumps for continuous subcutaneous insulin
infusion added new dimensions to control of diabetes during pregnancy. In this
report, we describe our experiences with 28 pregnant diabetic women offered ... Cited by 7 - Related articles - All 2 versions
JF Blicklé, N Hancu, M Piletic, V Profozic, M … - Diabetes Obes Metab, 2008 - interscience.wiley.com Methods: TULIP [Testing the Usefulness of gLargine when Initiated Promptly in
type 2 diabetes mellitus (T2DM)] was a 9-month, 12-visit, open-label,
multinational, multicentre, randomized study to evaluate starting glargine ... Cited by 2 - Related articles - All 2 versions
D Kernaghan, T Farrell, P Hammond, P Owen - European Journal of Obstetrics and Gynecology, 2007 - Elsevier Fetal hyperinsulinaemia secondary to maternal hyperglycaemia is considered to be
the driving force behind excessive fetal growth. We hypothesised that insulin
pump therapy (continuous subcutaneous insulin infusion, CSII) would improve ... Cited by 2 - Related articles - All 18 versions
K Cypryk, M Kosiński, P Kamińska, T Kozdraj, … - Polskie archiwum medycyny wewnȩtrznej, 2008 - ncbi.nlm.nih.gov OBJECTIVES: The aim of the study was to compare diabetes control and obstetrical
outcomes in pregnant women with type 1 diabetes treated during pregnancy with
either continuous subcutaneous insulin infusion (CSII) or multiple daily ... Cited by 1 - Related articles
XF Huang, JZ Chen - Obesity reviews: an official journal of the International …, 2009 - interscience.wiley.com Epidemiological studies have shown that obesity increases the risk of colon
cancer by 1.5–2 fold with obesity-associated colon cancer accounting for
14–35% of total incidence. Several factors, altered in obesity, may be ... Cited by 1 - Related articles - All 2 versions
O Cohen, N Keidar, M Simchen, B Weisz, M … - Gynecological Endocrinology, 2008 - informahealthcare.com Results. A total of 14 deliveries (10 singleton) were assessed. There were no
miscarriages, one baby that was born with a ventricular septal defect (VSD).
Glycemic control was within the acceptable guidelines. HbA1c (%) by ... Cited by 1 - Related articles - All 5 versions
